Gut-restricted FXR agonist fexaramine (Fex) induces browning white adipose tissue, increases the metabolic rate in brown adipose tissue, alters bile acid composition, and improves hepatic steatosis and insulin sensitivity [213]. This evidence concerns the gene NR1H4 and fatty liver disease.